Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer.
Bao PQ; Ramanathan RK; Krasinkas A; Bahary N; Lembersky BC; Bartlett DL; Hughes SJ; Lee KK; Moser AJ; Zeh HJ 3rd; Annals Of Surgical Oncology, 2011, vol. 18, issue 4, p 1122, ISSN 15344681. ISBN 15344681.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef